Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
5
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biotech
bristol-myers squibb
clinical trials
abbvie
aducanumab
amgen
astrazeneca
biogen
cancer
celgene
cystic fibrosis
deals
What
drug
5
×
week
5
×
bio
roundup
alzheimer’s
biogen
ceo
news
aces
acquisitions
adu
aducanumab
amyloid
angst
announced
annual
approved
assessed
attention
bagged
beats
bids
big
biggest
billions
biogen’s
biotech
brammer
build
buy
cholesterol
communities
company’s
complicated
conference
daniel
debut
depression
dire
dyne’s
Language
unset
Current search:
week
×
drug
×
" life sciences "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More